Home | All intervention

[RDF data]
Intervention #100431 (Dietary Supplement:Omega 3 Fatty Acids)

Resource URI: http://static.linkedct.org/resource/intervention/100431
linkedct:description The study medication will consist of combined EPA/DHA with a ratio of 2:1. Dosage will be titrated based on clinical response and side effects. The initial dose will be 1.2g/d. This will be increased gradually by 0.6 per 2 weeks to a possible maximum daily dose of 3.6 g/d. Patients will have to remain on a dose for 2 weeks to provide the opportunity to assess clinical response at any one dose. The total duration of the intervention will be 10 weeks.
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00962598>
linkedct:intervention_id 100431 (xsd:int)
linkedct:intervention_name Omega 3 Fatty Acids
linkedct:intervention_type Dietary Supplement
rdfs:label Intervention #100431 (Dietary Supplement:Omega 3 Fatty Acids)
rdf:type linkedct:intervention